Dr. Christine Lu-Emerson
Claim this profileMaine Medical Center- Scarborough Campus
Studies Glioblastoma
Studies Brain Tumor
6 reported clinical trials
13 drugs studied
Area of expertise
1Glioblastoma
MET negative
IDH negative
2Brain Tumor
IDH positive
1p/19q co-deletion positive
1p/19q positive
Affiliated Hospitals
Clinical Trials Christine Lu-Emerson is currently running
Tirabrutinib
for Central Nervous System Lymphoma
This trial is testing tirabrutinib alone and with other cancer drugs in patients with PCNSL. It targets those who haven't responded to previous treatments or are newly diagnosed. Tirabrutinib works by blocking a protein that helps cancer cells grow. Tirabrutinib was approved for use in treating primary central nervous system lymphoma.
Recruiting1 award Phase 210 criteria
Lenalidomide + Nivolumab
for Lymphoma
This trial tests a combination of drugs to treat a rare brain cancer. The treatment aims to starve the tumor, boost the immune system, and stop cancer cells from growing. It targets patients with primary CNS lymphoma who may not respond well to standard treatments.
Recruiting1 award Phase 119 criteria
More about Christine Lu-Emerson
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Christine Lu-Emerson has experience with
- Temozolomide
- Nivolumab
- Optune®
- Proton Beam Radiation Therapy
- IMRT (Intensity-Modulated Radiation Therapy)
- Ipilimumab
Breakdown of trials Christine Lu-Emerson has run
Glioblastoma
Brain Tumor
Anaplastic Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christine Lu-Emerson specialize in?
Christine Lu-Emerson focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved MET negative patients, or patients who are IDH negative.
Is Christine Lu-Emerson currently recruiting for clinical trials?
Yes, Christine Lu-Emerson is currently recruiting for 3 clinical trials in Scarborough Maine. If you're interested in participating, you should apply.
Are there any treatments that Christine Lu-Emerson has studied deeply?
Yes, Christine Lu-Emerson has studied treatments such as Temozolomide, Nivolumab, Optune®.
What is the best way to schedule an appointment with Christine Lu-Emerson?
Apply for one of the trials that Christine Lu-Emerson is conducting.
What is the office address of Christine Lu-Emerson?
The office of Christine Lu-Emerson is located at: Maine Medical Center- Scarborough Campus, Scarborough, Maine 04074 United States. This is the address for their practice at the Maine Medical Center- Scarborough Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.